Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyuki Mogi is active.

Publication


Featured researches published by Hiroyuki Mogi.


Bioorganic & Medicinal Chemistry Letters | 2011

KDR inhibitor with the intramolecular non-bonded interaction: conformation-activity relationships of novel indole-3-carboxamide derivatives.

Takahiro Honda; Hironori Nagahara; Hiroyuki Mogi; Masakazu Ban; Hiroyuki Aono

We previously reported that compound 1, having a similar conformation to PTK787 (2) by forming a pseudo ring structure with an intramolecular non-bonded S-O interaction, exhibited a potent inhibitory activity against VEGFR2 tyrosine kinase (KDR). Applying the ideas of pseudo ring formations, we have designed three types of novel indole carboxamide derivatives 5-7 with an intramolecular hydrogen bonding or non-bonded S-O interaction. We describe the design and synthesis of 5-7, and also discuss the relationships of their KDR inhibitory activity and conformations that were stabilized by their intramolecular non-bonded interactions.


Archive | 2005

Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity

Mamoru Matsuda; Toshiyuki Mori; Noriko Mishina; Hiroyuki Mogi; Minoru Yamamoto; Koushi Fujisawa; Yumi Hagiwara; Junko Fujikawa


Archive | 2007

Novel n-(2-aminophenyl)benzamide derivative having an urea structure

Hiroyuki Mogi; Hisashi Tajima; Noriko Mishina; Yusuke Yamazaki; Shinji Yoneda; Katsuhiko Watanabe; Junko Fujikawa; Minoru Yamamoto


Archive | 2008

Novel indole derivative having anti-angiogenic activity

Takahiro Honda; Hiroyuki Mogi; Hiroyuki Aono; Masakazu Ban


Archive | 2008

Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure

Hiroyuki Mogi; Hisashi Tajima; Noriko Mishina; Yusuke Yamazaki; Shinji Yoneda; Katsuhiko Watanabe; Junko Fujikawa; Minoru Yamamoto


Archive | 2010

Novel cyclic squaramide derivatives

Takahiro Honda; 本田 崇宏; Chikako Setoguchi; 瀬戸口 尋子; Hiroyuki Mogi; 寛幸 茂木; Fumio Tsuji; 文雄 辻; Hiroyuki Aono; 青野 浩之; Masakazu Ban; 正和 伴


Archive | 2008

NOVEL (2-AMINOPHENYL)PYRIDINECARBOXAMIDE DERIVATIVE HAVING UREA STRUCTURE

Hiroyuki Mogi; Hisashi Tajima; Noriko Mishina; Yusuke Yamazaki; Shinji Yoneda; Katsuhiko Watanabe; Junko Fujikawa; Minoru Yamamoto


Archive | 2008

Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient

Hisashi Tajima; Hiroyuki Mogi; Noriko Mishina; Yusuke Yamazaki; Shinji Yoneda; Katsuhiko Watanabe; Junko Fujikawa; Minoru Yamamoto


Archive | 2009

Thiophenediamine derivative having urea structure

Hiroyuki Mogi; Hisashi Tajima; Noriko Mishina; Yusuke Yamazaki; Shinji Yoneda; Katsuhiko Watanabe; Junko Fujikawa; Minoru Yamamoto


Archive | 2009

Neues thiophendiaminderivat mit harnstoffstruktur

Junko Fujikawa; Noriko Mishina; Hiroyuki Mogi; Hisashi Tajima; Katsuhiko Watanabe; Minoru Yamamoto; Yusuke Yamazaki; Shinji Yoneda

Collaboration


Dive into the Hiroyuki Mogi's collaboration.

Top Co-Authors

Avatar

Junko Fujikawa

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Minoru Yamamoto

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Noriko Mishina

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shinji Yoneda

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Hisashi Tajima

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Yusuke Yamazaki

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Aono

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Masakazu Ban

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Takahiro Honda

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Researchain Logo
Decentralizing Knowledge